A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
To establish the optimum injection rate for E7337 (Iomeron 350) in dynamic CT in patients who have hepatic lesions.The primary endpoint for efficacy is the contrast enhancement effect in the early arterial phase, and the primary safety endpoints are warming sensation and vascular pain.
Epistemonikos ID: 644ab43e85fd2ecb0cca2c7fc4a223e1c640e424
First added on: May 04, 2024